
Praj Industries, a key player in the bioeconomy and energy transition sector, has seen a significant drop in its stock price, falling by 6.72% to Rs 473.75.
This comes after the company reported a staggering 56.7% plunge in its net profit for Q4 FY25, which dropped to Rs 39.80 crore compared to Rs 91.85 crore in the same quarter last year.

But before you jump to conclusions, let’s dive into what’s behind these numbers.
Financial Breakdown: A Rocky Quarter
The company’s profit before tax (PBT) for Q4 FY25 was Rs 58.30 crore, marking a 52.6% year-on-year decrease and a slight 0.9% drop from Q3 FY25. The numbers don’t paint a rosy picture, but there’s more to the story than just the red ink.
EBITDA for the quarter stood at Rs 73.90 crore, a sharp 43.5% drop compared to Q4 FY24. However, it did show a modest 1.7% increase from Q3 FY25.
This improvement on a quarter-over-quarter basis suggests that Praj Industries might be finding some footing amid global challenges. The EBITDA margin stood at 8.6% for Q4 FY25, down from 12.83% in Q4 FY24 but better than the 8.52% from the previous quarter.
But what does all this mean for the average investor or customer? The key takeaway is that Praj Industries, while facing tough times, is still managing to hold its ground, and there are glimmers of recovery in certain areas.
Also Read PNB Housing Finance Rises 8.33% After Posting 25% Profit Growth in Q4
The Global Impact: Order Intake and Backlog
Despite the downturn, Praj Industries reported an increase in its order intake. The company secured Rs 1,032 crore in orders for Q4 FY25, which is higher than the Rs 924 crore it posted during the same period last year. However, this is still lower than the Rs 1,053 crore it secured in Q3 FY25.
One notable shift is the company’s growing international presence, with 39% of its Q4 FY25 order book coming from global markets.
This is a clear sign that Praj is not only focusing on the Indian market but is also expanding its footprint internationally, which might prove beneficial in the long run.
Yearly Performance: A Full-Year Review
For FY25, Praj Industries reported a 22.8% drop in net profit, bringing it down to Rs 218.90 crore. Operational income also fell by 6.9%, coming in at Rs 3,228 crore for the year.
This decline in revenue was mirrored by a 16.3% drop in EBITDA, which stood at Rs 324.80 crore.
On a positive note, Praj’s consolidated order backlog as of March 31, 2025, rose to Rs 4,293 crore, up from Rs 3,855 crore in FY24. This indicates that the company has a solid pipeline for the future, even if the short-term outlook seems shaky.
Also Read Adani Green Energy Share Price Rises After Strong Q4 Results
Looking Ahead: Optimism Amid the Struggles
Despite the challenging financial results, CEO and MD Shishir Joshipura remains optimistic.
He pointed to the completion of the EBP20 program ahead of schedule as a bright spot, which could pave the way for expanding bioenergy in the future. Additionally, Praj Industries is ramping up its international business, with its GenX facility now ready to serve the ETCA segment globally.
“The developments taking place in the bioeconomy and energy transition space are crucial for our long-term growth,” Joshipura noted. This sentiment reflects a forward-looking strategy that focuses on global expansion and the growing importance of bioenergy.
Dividend and Shareholder Returns
In a move to reassure investors, Praj Industries’ board proposed a final dividend of Rs 6 per equity share for FY25. While dividends won’t solve all the company’s challenges, they are a sign that Praj is committed to rewarding its shareholders even amid financial struggles.
The Bigger Picture: Is This Just a Bump in the Road?
While the current quarter’s performance might be concerning, it’s essential to keep an eye on the company’s strategic plans and its efforts to expand globally.
With growing demand for sustainable energy solutions and bioeconomy-related technologies, Praj Industries could very well weather the storm in the coming quarters.
For now, the company’s stock may look like it’s on a downhill slope, but investors who understand the long-term play in the bioenergy and agri-process industries might still find value here.